Abstract
This Life Science Insights update provides our best estimates of the worldwide
bio/pharma revenue of the top 50 IT vendors in CY04. This update provides one
measurement of a vendor's strength in or reliance on the bio/pharma industry.
Although this document is intended to provide a macro view of IT vendor revenue
in bio/pharma, we recognize the need for more granular segmentations. As such,
we will continue to extend our research in this area and can develop specific
requests on a custom basis.
View Cart
